ÂÜÀòÂÒÂ×

Abudukadier Abulizi, MD, PhD has a strong background in research and scientific roles. Currently, they are serving as the Principle Scientist at EvolveImmune Therapeutics since May 2021. Prior to this, they worked at Yale University School of Medicine for a significant period. From July 2017 to May 2021, they held the position of Associate Research Scientist. Before that, from October 2014 to July 2016, they worked as a Postdoctoral Associate, and from October 2013 to October 2014, they served as a Postdoctoral Fellow. Abudukadier Abulizi's work experience shows their expertise and dedication in the field of medical research.

Abudukadier Abulizi, MD, PhD pursued their education with a focus on Medicine and Non-alcoholic Fatty Liver Disease. Abudukadier completed their Doctor of Medicine (MD) degree at Xinjiang Medical University from 1998 to 2004. Following that, they pursued advanced studies at Kyoto University, where they obtained a Doctor of Philosophy (PhD) degree specializing in Non-alcoholic Fatty Liver Disease from 2007 to 2013.